Bicara Therapeutics Common Stock Probability of Future Stock Price Finishing Under 10.01
| BCAX Stock | 20.79 0.17 0.81% |
Bicara |
Bicara Therapeutics Target Price Odds to finish below 10.01
The tendency of Bicara Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to 10.01 or more in 90 days |
| 20.79 | 90 days | 10.01 | near 1 |
Based on a normal probability distribution, the odds of Bicara Therapeutics to drop to 10.01 or more in 90 days from now is near 1 (This Bicara Therapeutics Common probability density function shows the probability of Bicara Stock to fall within a particular range of prices over 90 days) . Probability of Bicara Therapeutics price to stay between 10.01 and its current price of 20.79 at the end of the 90-day period is about 23.68 .
Given the investment horizon of 90 days Bicara Therapeutics has a beta of 0.21 suggesting as returns on the market go up, Bicara Therapeutics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Bicara Therapeutics Common will be expected to be much smaller as well. Additionally Bicara Therapeutics Common has an alpha of 0.3784, implying that it can generate a 0.38 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Bicara Therapeutics Price Density |
| Price |
Predictive Modules for Bicara Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Bicara Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Bicara Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Bicara Therapeutics is not an exception. The market had few large corrections towards the Bicara Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Bicara Therapeutics Common, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Bicara Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.38 | |
β | Beta against Dow Jones | 0.21 | |
σ | Overall volatility | 2.50 | |
Ir | Information ratio | 0.05 |
Bicara Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Bicara Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Bicara Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Bicara Therapeutics had very high historical volatility over the last 90 days | |
| Bicara Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| Latest headline from thelincolnianonline.com: Braidwell LP Acquires New Shares in Bicara Therapeutics Inc. |
Bicara Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Bicara Stock often depends not only on the future outlook of the current and potential Bicara Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bicara Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Shares Float | 29.6 M |
Bicara Therapeutics Technical Analysis
Bicara Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Bicara Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Bicara Therapeutics Common. In general, you should focus on analyzing Bicara Stock price patterns and their correlations with different microeconomic environments and drivers.
Bicara Therapeutics Predictive Forecast Models
Bicara Therapeutics' time-series forecasting models is one of many Bicara Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Bicara Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Bicara Therapeutics
Checking the ongoing alerts about Bicara Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Bicara Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Bicara Therapeutics had very high historical volatility over the last 90 days | |
| Bicara Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| Latest headline from thelincolnianonline.com: Braidwell LP Acquires New Shares in Bicara Therapeutics Inc. |
Additional Tools for Bicara Stock Analysis
When running Bicara Therapeutics' price analysis, check to measure Bicara Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bicara Therapeutics is operating at the current time. Most of Bicara Therapeutics' value examination focuses on studying past and present price action to predict the probability of Bicara Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bicara Therapeutics' price. Additionally, you may evaluate how the addition of Bicara Therapeutics to your portfolios can decrease your overall portfolio volatility.